References
- Andre, A., Juaneda, P., Sebedio, J., & Chardigny, J. (2006). Plasmalogen metabolism-related enzymes in rat brain during aging: Influence of n-3 fatty acid intake. Biochimie, 88, 103–111. doi:10.1016/j.biochi.2005.06.010
- Appolinário, P. P., Medinas, D. B., Chaves-Filho, A. B., Genaro-Mattos, T. C., Cussiol, J. R. R., Netto, L. E. S., … Miyamoto, S. (2015). Oligomerization of Cu, Zn-Superoxide Dismutase (SOD1) by docosahexaenoic acid and its hydroperoxides in vitro: Aggregation dependence on fatty acid unsaturation and thiols. PLoS One, 10, e0125146. doi:10.1371/journal.pone.0125146
- Bazan, N. G. (2005). Neuroprotectin D1 (NPD1): A DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathology, 15, 159–166. doi:10.1111/j.1750-3639.2005.tb00513.x
- Braverman, N. E., & Moser, A. B. (2012). Functions of plasmalogen lipids in health and disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1822, 1442–1452. doi:10.1016/j.bbadis.2012.05.008
- DeMar, J. C., Ma, K., Chang, L., Bell, J. M., & Rapoport, S. I. (2005). α-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. Journal of Neurochemistry, 94, 1063–1076. doi:10.1111/j.1471-4159.2005.03258.x
- Farooqui, A. A. (2010). Studies on plasmalogen-selective phospholipase A2 in brain. Molecular Neurobiology, 41, 267–273. doi:10.1007/s12035-009-8091-y
- Farooqui, A. A., & Horrocks, L. A. (2006). Phospholipase A2-generated lipid mediators in the brain: The good, the bad, and the ugly. Neuroscientist, 12, 245–260. doi:10.1177/1073858405285923
- Fecchio, C., De Franceschi, G., Relini, A., Greggio, E., Dalla Serra, M., Bubacco, L., & de Laureto, P. P. (2013). α-Synuclein oligomers induced by docosahexaenoic acid affect membrane integrity. PLoS One, 8, e82732. doi:10.1371/journal.pone.0082732
- Freund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A., … Palmblad, J. (2006). ω-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD Study: A randomized double-blind trial. Archives of Neurology, 63, 1402–1408. doi:10.1001/archneur.63.10.1402.
- Goodenowe, D. B., Cook, L. L., Liu, J., Lu, Y., Jayasinghe, D. A., Ahiahonu, P. W., … Krenitsky, K. F. (2007). Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer’s disease and dementia. Journal of Lipid Research, 48, 2485–2498. doi:10.1194/jlr.P700023-JLR200
- Hermann, P. M., Watson, S. N., & Wildering, W. C. (2014). Phospholipase A2–nexus of aging, oxidative stress, neuronal excitability, and functional decline of the aging nervous system? Insights from a snail model system of neuronal aging and age-associated memory impairment. Frontiers in genetics, 5, 1–18. doi:10.3389/fgene.2014.00419.
- Kim, H.-Y. (2007). Novel metabolism of docosahexaenoic acid in neural cells. Journal of Biological Chemistry, 282, 18661–18665. doi:10.1074/jbc.R700015200
- Kosicek, M., & Hecimovic, S. (2013). Phospholipids and Alzheimer’s disease: Alterations, mechanisms and potential biomarkers. International Journal of Molecular Sciences, 14, 1310–1322. doi:10.3390/ijms14011310
- Quinn, J. F., Raman, R., Thomas, R. G., Yurko-Mauro, K., Nelson, E. B., Van Dyck, C., & Weiner, M. (2010). Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA, 304, 1903–1911. doi:10.1001/jama.2010.1510.
- Rapoport, S. I., Ramadan, E., & Basselin, M. (2011). Docosahexaenoic acid (DHA) incorporation into the brain from plasma, as an in vivo biomarker of brain DHA metabolism and neurotransmission. Prostaglandins & Other Lipid Mediators, 96, 109–113. doi:10.1016/j.prostaglandins.2011.06.003